blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3857227

EP3857227 - COMPOSITION FOR REMOVING HAPTEN INTERFERENCE FROM ASSAYS [Right-click to bookmark this link]
Former [2021/31]METHODS AND COMPOSITIONS FOR REMOVING BIOTIN INTERFERENCE FROM ASSAYS USING CYCLODEXTRIN TRAPS
[2023/17]
StatusNo opposition filed within time limit
Status updated on  30.08.2024
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  22.09.2023
FormerGrant of patent is intended
Status updated on  04.04.2023
FormerExamination is in progress
Status updated on  12.08.2022
FormerRequest for examination was made
Status updated on  02.07.2021
FormerThe international publication has been made
Status updated on  05.04.2020
Most recent event   Tooltip30.08.2024No opposition filed within time limitpublished on 02.10.2024 [2024/40]
Applicant(s)For all designated states
Siemens Healthcare Diagnostics Inc.
511 Benedict Avenue
Tarrytown, NY 10591 / US
[2021/31]
Inventor(s)01 / WEI, Tie
97 Ascension Drive
Wilmington, Delaware 19808 / US
 [2021/31]
Representative(s)Schweitzer, Klaus
Plate Schweitzer Zounek Patentanwälte Rheingaustrasse 196
65203 Wiesbaden / DE
[2021/31]
Application number, filing date19868091.019.09.2019
[2021/31]
WO2019US51880
Priority number, dateUS201862735909P25.09.2018         Original published format: US 201862735909 P
[2021/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020068544
Date:02.04.2020
Language:EN
[2020/14]
Type: A1 Application with search report 
No.:EP3857227
Date:04.08.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 02.04.2020 takes the place of the publication of the European patent application.
[2021/31]
Type: B1 Patent specification 
No.:EP3857227
Date:25.10.2023
Language:EN
[2023/43]
Search report(s)International search report - published on:US02.04.2020
(Supplementary) European search report - dispatched on:EP05.10.2021
ClassificationIPC:G01N33/53, G01N33/543
[2021/44]
CPC:
G01N33/5306 (EP,US); C07K16/44 (US); G01N1/34 (US);
G01N33/543 (EP,US); G01N33/54313 (US); G01N2400/18 (US)
Former IPC [2021/31]G01N33/543
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/31]
TitleGerman:ZUSAMMENSETZUNG ZUR ENTFERNUNG VON HAPTEN-INTERFERENZ AUS ASSAYS[2023/17]
English:COMPOSITION FOR REMOVING HAPTEN INTERFERENCE FROM ASSAYS[2023/17]
French:COMPOSITION POUR ÉLIMINER L'INTERFÉRENCE D'HAPTÈNE DANS DES ESSAIS[2023/17]
Former [2021/31]VERFAHREN UND ZUSAMMENSETZUNGEN ZUR ENTFERNUNG VON BIOTIN-INTERFERENZ AUS ASSAYS UNTER VERWENDUNG VON CYCLODEXTRINFALLEN
Former [2021/31]METHODS AND COMPOSITIONS FOR REMOVING BIOTIN INTERFERENCE FROM ASSAYS USING CYCLODEXTRIN TRAPS
Former [2021/31]PROCÉDÉS ET COMPOSITIONS POUR ÉLIMINER L'INTERFÉRENCE DE LA BIOTINE DANS DES ESSAIS AU MOYEN DE PIÈGES À CYCLODEXTRINE
Entry into regional phase20.04.2021National basic fee paid 
20.04.2021Search fee paid 
20.04.2021Designation fee(s) paid 
20.04.2021Examination fee paid 
Examination procedure20.04.2021Examination requested  [2021/31]
29.04.2022Amendment by applicant (claims and/or description)
17.08.2022Despatch of a communication from the examining division (Time limit: M04)
20.12.2022Reply to a communication from the examining division
05.04.2023Communication of intention to grant the patent
20.07.2023Receipt of the translation of the claim(s)
11.08.2023Fee for grant paid
11.08.2023Fee for publishing/printing paid
Opposition(s)26.07.2024No opposition filed within time limit [2024/40]
Fees paidRenewal fee
17.09.2021Renewal fee patent year 03
19.09.2022Renewal fee patent year 04
18.09.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT25.10.2023
CZ25.10.2023
DK25.10.2023
EE25.10.2023
ES25.10.2023
HR25.10.2023
IT25.10.2023
LT25.10.2023
LV25.10.2023
NL25.10.2023
PL25.10.2023
RO25.10.2023
RS25.10.2023
SE25.10.2023
SK25.10.2023
SM25.10.2023
BG25.01.2024
NO25.01.2024
GR26.01.2024
IS25.02.2024
PT26.02.2024
[2024/36]
Former [2024/35]AT25.10.2023
CZ25.10.2023
DK25.10.2023
EE25.10.2023
ES25.10.2023
HR25.10.2023
LT25.10.2023
LV25.10.2023
NL25.10.2023
PL25.10.2023
RO25.10.2023
RS25.10.2023
SE25.10.2023
SM25.10.2023
BG25.01.2024
NO25.01.2024
GR26.01.2024
IS25.02.2024
PT26.02.2024
Former [2024/34]AT25.10.2023
DK25.10.2023
EE25.10.2023
ES25.10.2023
HR25.10.2023
LT25.10.2023
LV25.10.2023
NL25.10.2023
PL25.10.2023
RS25.10.2023
SE25.10.2023
SM25.10.2023
BG25.01.2024
NO25.01.2024
GR26.01.2024
IS25.02.2024
PT26.02.2024
Former [2024/33]AT25.10.2023
DK25.10.2023
ES25.10.2023
HR25.10.2023
LT25.10.2023
LV25.10.2023
NL25.10.2023
PL25.10.2023
RS25.10.2023
SE25.10.2023
SM25.10.2023
BG25.01.2024
NO25.01.2024
GR26.01.2024
IS25.02.2024
PT26.02.2024
Former [2024/26]AT25.10.2023
ES25.10.2023
HR25.10.2023
LT25.10.2023
LV25.10.2023
NL25.10.2023
PL25.10.2023
RS25.10.2023
SE25.10.2023
BG25.01.2024
NO25.01.2024
GR26.01.2024
IS25.02.2024
PT26.02.2024
Former [2024/25]AT25.10.2023
ES25.10.2023
HR25.10.2023
LT25.10.2023
NL25.10.2023
PL25.10.2023
RS25.10.2023
SE25.10.2023
BG25.01.2024
NO25.01.2024
GR26.01.2024
IS25.02.2024
PT26.02.2024
Former [2024/23]AT25.10.2023
ES25.10.2023
LT25.10.2023
NL25.10.2023
BG25.01.2024
GR26.01.2024
IS25.02.2024
PT26.02.2024
Former [2024/21]LT25.10.2023
NL25.10.2023
BG25.01.2024
GR26.01.2024
IS25.02.2024
Former [2024/20]NL25.10.2023
GR26.01.2024
IS25.02.2024
Former [2024/17]NL25.10.2023
Documents cited:Search[Y]US5212063  (OFENLOCH-HAEHNLE BEATUS [DE], et al) [Y] 4 * see col. 1-4, example 2 *;
 [A]US5863740  (KIENTSCH-ENGEL ROSEMARIE [DE], et al) [A] 1-10* the whole document *;
 [XY]WO2014030002  (UNIV KENT CANTERBURY [GB]) [X] 1-3,5-8,10 * see p. 6-7, 11-12, Fig. 1 * [Y] 4;
 [XY]  - HOLZINGER MICHAEL ET AL, "Biotin-[beta]-Cyclodextrin: A New Host-Guest System for the Immobilization of Biomolecules", LANGMUIR, US, (20120816), vol. 28, no. 34, doi:10.1021/la301963v, ISSN 0743-7463, pages 12569 - 12574, XP055843312 [X] 1-3,5-10 * see abstract, p. 12569-12572, Fig. 6 * [Y] 4

DOI:   http://dx.doi.org/10.1021/la301963v
 [X]  - Flamigni Lucia, "Inclusion of Fluorescein and Halogenated Derivatives in a-, /?-, and 7-Cyclodextrins. A Steady-State and Picosecond Time-Resolved Study", J. Phys. Chem, (19930101), pages 9566 - 9572, URL: https://pubs.acs.org/doi/pdf/10.1021/j100140a006, (20210921), XP055843340 [X] 1,2,5-10 * see abstract *
 [XY]  - BEN AISSA A. ET AL, "Magnetic molecularly imprinted polymer for the isolation and detection of biotin and biotinylated biomolecules", BIOSENSORS AND BIOELECTRONICS, Amsterdam , NL, (20170201), vol. 88, doi:10.1016/j.bios.2016.07.096, ISSN 0956-5663, pages 101 - 108, XP055843332 [X] 1,2,5,7,10 * see Fig. 1, p. 102, 106-107 * [Y] 4

DOI:   http://dx.doi.org/10.1016/j.bios.2016.07.096
International search[Y]US4426292  (WERNICK DAVID L [US], et al) [Y] 1-2, 9-10, 3-8 * ; entire document, especially abstract, Figs 1-5, col 3 lines 50-55, col 5 lines 35-49 *;
 [YD]US5212063  (OFENLOCH-HAEHNLE BEATUS [DE], et al) [YD] 1-2, 9-10, 3-8 * ; entire document, especially abstract, claim 7, claim 9, col 1 lines 25-49, col 3 lines 55-65, col 4 lines 32-39 *;
 [A]US6231982  (WANG CHENGRONG [US]) [A] 1-10* ; entire document *
Examination   - Mathapa Baghali G. ET AL, "Fabrication of novel cyclodextrin-polyallylamine hydrochloride co-polymeric microcapsules by templating oil-in-water emulsions", Soft Matter, GB, (20130101), vol. 9, no. 19, doi:10.1039/c3sm27935a, ISSN 1744-683X, page 4780, XP055949911

DOI:   http://dx.doi.org/10.1039/c3sm27935a
by applicantUS5212063
 US5340716
 US8252605
 WO2014030002
    - M. HOLZINGER et al., "Biotin-P-Cyclodextrin: A New Host-Guest System for the Immobilization of Biomolecules", Langmuir, (20120000), vol. 28, doi:10.1021/la301963v, pages 12569 - 12574, XP055843312

DOI:   http://dx.doi.org/10.1021/la301963v
    - L. FLAMIGNI, "Inclusion of Fluorescein and Halogenated Derivatives, in α-, β-, and γ-Cyclodextrins", J. Phys. Chem., (19930000), vol. 97, pages 9566 - 9572, XP055843340
    - A. BEN AISSA et al., "Magnetic molecularly imprint polymer for the isolation and detection of biotin and biotinylated biomolecules", Biosensors and Bioelectronics, (20170000), vol. 88, doi:10.1016/j.bios.2016.07.096, pages 101 - 108, XP055843332

DOI:   http://dx.doi.org/10.1016/j.bios.2016.07.096
    - B.G. MATHAPA et al., "Fabrication of novel cyclodextrin-polyallylamine hydrochloride co-polymeric microcapsules by templating oil-in-water emulsions", Soft Matter, (20130000), vol. 9, pages 4780 - 4788
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.